Saturday Program

Simultaneous Sessions | Clinical Trial Update | Science in progress | Hematology-in-focus Session | Lunch Debates | Meet-the-Expert | 5th EHA / ASH Joint Symposium | EHA Business Meeting | Jean Bernard Lifetime Achievement Award | Presidential Symposium | Plenary Session 1 | Poster Session II

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Hall A1

CONTROVERSIES IN GENOMEWIDE APPROACHES IN HEMATOLOGICAL MALIGNANCIES
Chair: S Izraeli (Sheba Medical Center Tel Hashomer, Ramat Gan, Israel)

SINGLE NUCLEOTIDE POLYMORPHISM MICROARRAYS IN ACUTE LYMPHOBLASTIC LEUKEMIA
J Downing (St. Jude Children's Research Hospital, Memphis, USA)

HOW TO INTERPRET GENE EXPRESSION STUDIES IN LYMPHOMA?
A Rosenwald (University of Würzburg, Würzburg, Germany)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Hall A2

MOLECULAR CONTROL OF STEM CELL MAINTENANCE
Chair: W Fibbe (University Medical Center, Leiden, The Netherlands)

HIBERNATION OF HEMATOPOIETIC STEM CELLS IN THE BONE MARROW NICHE
H Nakauchi (University of Tokyo, Tokyo, Japan)

DORMANT AND ACTIVATED STEM CELLS DURING HOMEOSTASIS INJURY AND CANCER
A Trumpp (ISREC, Lausanne, Switzerland)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Auditorium 1

WHO LYMPHOMA CLASSIFICATION 2008
Chair: W Klapper (University Hôspital Schleswig-Holstein, Kiel, Germany)

B-CELL LYMPHOMA
E Campo (Hospital Clinic, Barcelona, Spain)

T-CELL LYMPHOMA
G Delsol (Laboratoire d'Anatomie Pathologique, Toulouse Cedex, France)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Hall A3

JAK2 MUTATIONS IN MYELOPROLIFERATIVE DISORDERS
Chair: N Casadevall (Hôpital Saint Antoine, Paris, France)

DEVELOPMENT OF JAK2 INHIBITORS
G Gilliland (Harvard Medical School, Boston, USA)

MOLECULAR MECHANISMS AND CLINICAL PHENOTYPES
A Green (Cambridge Institute for Medical Research, Cambridge, United Kingdom)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Auditorium 2

LONG-TERM SEQUELAE AFTER HODGKIN LYMPHOMA TREATMENT
Chair: L Specht (Rigshospitalet, Copenhagen, Denmark)

SECOND MALIGNANCIES AFTER HODGKIN LYMPHOMA TREATMENT
J Franklin (University of Cologne, Cologne, Germany)

HOW CANCER THERAPY FOR HODGKIN LYMPHOMA CAN BREAK YOUR HEART
L Constine (University of Rochester Medical Center, Rochester, USA)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Hall C1

CELLULAR PATHOGENESIS OF SEPSIS
Chair: B Biemond (Academic Medical Center, Amsterdam, The Netherlands)

ACTIVATION AND DEACTIVATION OF LEUKOCYTES IN SEPSIS
J-M Cavaillon (Institut Pasteur, Paris, France)

THE ROLE OF PLATELETS AND HEMOSTASIS IN SEPSIS
A Goodall (University of Leicester, Leicester, United Kingdom)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Room: Hall C2

BLEEDING DISORDERS
Chair: E Berntorp (Malmö University Hospital, Malmö, Sweden)

FVIII AND MECHANISM OF IMMUNE SYSTEM ACTIVATION
S Lacroix-Desmazes (INSERM, Paris, France)

GENE THERAPY FOR HEMOPHILIA
A Nathwani (University College London, London, United Kingdom)